| 4SC AG |
| aap Implantate AG |
| Abbott Laboratories Ltd |
| Action Pharma A/S |
| Adamant Biomedical Investments |
| Adamant Ventures |
| Addex Pharmaceuticals Ltd |
| Aescap Venture |
| Alta Partners |
| Ambrilia Biopharma Inc. |
| AM-Pharma B.V. |
| AmVac AG |
| Andhra Jyothy |
| Apollo Hospitals Educational & Research Foundation Research Centre |
| Arana Therapeutics Ltd. |
| Aravis Venture Associates AG |
| Archimedes Pharma Ltd. |
| Atlantic Healthcare Limited |
| Atlas Venture |
| Avir Green Hills Biotechnology AG |
| Axentis Pharma AG |
| BankInvest Biomedical Venture |
| BB Biotech Ventures |
| Bio*One Capital Pte Ltd |
| BioConnect AG |
| BioGeneration Ventures |
| BioMarin Pharmaceuticals Inc |
| BioMedInvest AG |
| BioMS Medical Corp. |
| Biotie Therapies Corp. |
| Blueprint Life Science Group |
| Breslin AG |
| Brose Trust AG |
| BTG International |
| Cambridge Consultants Ltd |
| CardioLa Ltd |
| CBT Advisors |
| Cellerix SA |
| Cerimon Pharmaceuticals, Inc. |
| Chemgenex Pharmaceuticals |
| CMZ-Assay GmbH |
| CNSystems Medizintechnik GmbH |
| Cosmo Pharmaceuticals S.p.A. |
| Creathor Venture Management GmbH |
| Credit Suisse |
| dconsult |
| Deloitte AG |
| Dermasuisse |
| Deutsche Bank AG |
| DyoDelta Biosciences |
| Earlybird Venture Capital |
| Edmond de Rothschild Investment Partners |
| EFG Private Bank AG |
| Equity Development Ltd. |
| ESBATech AG |
| ETV Capital |
| European Investment Fund |
| EUSA Pharma |
| EVA - the Basel life sciences start-up agency |
| Evolva SA |
| Ferghana Partners |
| Forbion Capital Partners |
| Fulcrum Pharma (Europe) Ltd |
| Gilde Investment Management B.V. |
| GILUPI GmbH |
| Global Life Science Ventures |
| Glycotope GmbH |
| Goodvent - Beteiligungsnehmer |
| Grahaem Brown Consulting Limited |
| Greater Zurich Area |
| Haemacure Corporation |
| Haemostatix Ltd |
| HBM Partners AG |
| Helvea SA |
| Heptares Therapeutics Ltd |
| High-Tech Gründerfonds Management |
| Hitec Capital SA |
| IMI Intelligent Medical Implants AG |
| Innate Pharma SAS |
| Jado Technologies |
| JSB Partners |
| Katan Associates |
| Kresta, Schnider & Partners AG |
| Kuros Biosurgery AG |
| Landsbanki Kepler |
| LaVoie Group |
| Life Science & Financing - BRESLIN |
| LifeCycle Pharma A/S |
| LSP |
| Matignon Technologies |
| MBM ScienceBridge GmbH |
| MC Services |
| Medicyte GmbH |
| Merck & Co., Inc |
| Merck Serono International S.A. |
| Merrion Pharmaceuticals, Ltd. |
| MetGen Oy |
| Mobidiag Oy |
| Molecular Partners AG |
| MolMed S.p.A |
| MorphoSys AG |
| N.M Rothschild & Sons Ltd |
| NatImmune A/S |
| NBGI Ventures |
| Nextech Venture |
| NGN Capital LLC |
| Nitec Pharma AG |
| Noble Fund Managers |
| Northern Venture Managers Limited |
| Novartis AG |
| Novartis International AG |
| Novartis Pharma AG |
| Novartis Pharmaceuticals |
| Novartis Vaccines & Diagnostics |
| Novartis Venture Funds |
| NovImmune SA |
| Nventa Biopharmaceuticals |
| NZB Neue Zurcher Bank |
| Objective Capital |
| OctoPlus N.V. |
| Onelife Advisors SA |
| onepharm Research & Development GmbH |
| OphthalmoPharma |
| Orexo AB |
| Oxford Genome Sciences Ltd. |
| PanGenetics UK Ltd. |
| Parish Capital Advisors Europe, LLP |
| Paul Capital Partners |
| Pepscan Holding NV |
| PharmaVentures Ltd. |
| Phenomenome Discoveries Inc |
| Piper Jaffray Ltd |
| PricewaterhouseCoopers |
| PricewaterhouseCoopers AG |
| Probiodrug AG |
| Pronostics Ltd. |
| Pronota N.V. |
| Quest Management NV |
| Remaco Merger AG |
| Reuters |
| Ruston Poole International Ltd |
| S.M.R. Interimsmanagement and Consulting GmbH |
| Sal. Oppenheim Jr. & Cie |
| Santaris Pharma A/S |
| Sectoral Asset Management |
| Selvita Sp. z o.o. |
| Sensimed AG |
| Seventure Partners |
| Silence Therapeutics AG |
| Simulations Plus, Inc. |
| Sofinnova Partners |
| Solvias AG |
| Stromedix, Inc |
| Summit plc |
| Swiss Equity Magazine |
| SWX Swiss Exchange AG |
| Synosia Therapeutics |
| Taylor Wessing |
| Tech Investor Ltd. |
| Technology Consulting |
| Terra Rossa Capital Pty Ltd |
| The BioScience Ventures Group |
| The International Entrepreneur Fund |
| The Medicines Company (Schweiz) GmbH |
| The Rainbow Seed Fund |
| THE ZENE CAPITAL GmbH |
| TopoTarget A/S |
| Trigon Medical AG |
| Trout Group International LLC |
| Tudor Reilly |
| TVM Capital |
| Ventech |
| Vironova AB |
| Warburg Pincus LLC |
| Wellington Partners |
| Widmann Associates |
| Wilex AG |
| Xeno Medical, Ltd |
| Ysios Capital Partners SGECR SA |